Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: J Heart Lung Transplant. 2016 Jul 15;35(11):1295–1302. doi: 10.1016/j.healun.2016.06.022

Table 2.

Baseline Characteristics of Patients in the CTOT05 Study

Variable No CAV
(n = 66)
CAV
(n = 15)
p-value
Change in mean
  MIT (mm)
0.03 ± 0.01 0.17 ± 0.04 <0.001
Male sex 74% 93% 0.17
White race 74% 80% 0.75
Diabetes 32% 40% 0.56
BMI 27.6 ± 1.3 25.6 ± 0.6 0.18
Rejection 14% 7% 0.74
Total cholesterol
  (mg/dl)
138 ± 12.7 139 ± 5.2 0.95
HDL (mg/dl) 49 ± 2.8 39 ± 2.9 0.1
LDL (mg/dl) 76 ± 3.8 83 ± 9.4 0.48
Triglyceride (mg/dl) 77 ± 4.2 85 ± 11.7 0.51

BMI, body mass index; CAV, cardiac allograft vasculopathy; CTOT05, Clinical Trials in Organ Transplantation 05; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MIT, maximal intimal thickness.